Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting

Introduction: Hyperprogressive disease (HPD) is a state of accelerated tumor growth from cancer immunotherapy, associated with poor outcome. The reported incidence is 6% to 29% among studies using varying definitions of HPD, with no predictive biomarkers. Tumor infiltrating lymphocytes (TILs) are pr...

Full description

Bibliographic Details

Published in:	Technology in Cancer Research & Treatment
Main Authors:	Yada Kanjanapan MBBS, Geetha Guduguntla MBBS, Ashwati Krishnan Varikara MBBS, Jeremy Szajer MBBS, Desmond Yip MBBS, John Cockburn MBBS, Mitali Fadia MBBS
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-10-01
Online Access:	https://doi.org/10.1177/15330338231209129